These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12094972)

  • 1. Monte Carlo calculations of dosimetry parameters of the urocor prostaseed 125I source.
    Li Z
    Med Phys; 2002 Jun; 29(6):1029-34. PubMed ID: 12094972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo calculation of dosimetry parameters for the IR08-103Pd brachytherapy source.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Med Phys; 2010 Jun; 37(6):2509-15. PubMed ID: 20632562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
    Medich DC; Munro JJ
    Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric parameters of the new design (103)Pd brachytherapy source based on Monte Carlo study.
    Saidi P; Sadeghi M; Shirazi A; Tenreiro C
    Phys Med; 2012 Jan; 28(1):13-8. PubMed ID: 21251862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monte Carlo and experimental dosimetry of an 1251 brachytherapy seed.
    Dolan J; Lia Z; Williamson JF
    Med Phys; 2006 Dec; 33(12):4675-84. PubMed ID: 17278820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
    Aryal P; Molloy JA; Rivard MJ
    Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo dosimetry of the selectSeed 125I interstitial brachytherapy seed.
    Karaiskos P; Papagiannis P; Sakelliou L; Anagnostopoulos G; Baltas D
    Med Phys; 2001 Aug; 28(8):1753-60. PubMed ID: 11548946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monte Carlo calculations and experimental measurements of dosimetry parameters of a new 103Pd source.
    Li Z; Palta JR; Fan JJ
    Med Phys; 2000 May; 27(5):1108-12. PubMed ID: 10841416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
    Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
    Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric characteristic of a new 125I brachytherapy source.
    Sadeghi M; Khanmohammadi Z
    Radiat Prot Dosimetry; 2011 Nov; 147(3):451-6. PubMed ID: 21233096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and Monte Carlo determination of the TG-43 dosimetric parameters for the model 9011 THINSeed brachytherapy source.
    Kennedy RM; Davis SD; Micka JA; DeWerd LA
    Med Phys; 2010 Apr; 37(4):1681-8. PubMed ID: 20443489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
    Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
    Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the IsoAid ADVANTAGE (125)I brachytherapy source dosimetric parameters using Monte Carlo simulation.
    Sadeghi M; Hamed Hosseini S
    Appl Radiat Isot; 2010 Jan; 68(1):211-3. PubMed ID: 19762248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric parameters for three low-energy brachytherapy sources using the Monte Carlo N-particle code.
    DeMarco JJ; Hugo G; Solberg TD
    Med Phys; 2002 May; 29(5):662-8. PubMed ID: 12033560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental determination of the TG-43 dosimetric characteristics of EchoSeed model 6733 I25I brachytherapy source.
    Meigooni AS; Dini SA; Sowards K; Hayes JL; Al-Otoom A
    Med Phys; 2002 Jun; 29(6):939-42. PubMed ID: 12094988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brachytherapy dosimetry of 125I and 103Pd sources using an updated cross section library for the MCNP Monte Carlo transport code.
    Bohm TD; DeLuca PM; DeWerd LA
    Med Phys; 2003 Apr; 30(4):701-11. PubMed ID: 12722822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of encapsulated 170Tm sources for their potential use in brachytherapy.
    Ballester F; Granero D; Perez-Calatayud J; Venselaar JL; Rivard MJ
    Med Phys; 2010 Apr; 37(4):1629-37. PubMed ID: 20443484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
    Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
    Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EchoSeed Model 6733 Iodine-125 brachytherapy source: improved dosimetric characterization using the MCNP5 Monte Carlo code.
    Mosleh-Shirazi MA; Hadad K; Faghihi R; Baradaran-Ghahfarokhi M; Naghshnezhad Z; Meigooni AS
    Med Phys; 2012 Aug; 39(8):4653-9. PubMed ID: 22894389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.